These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29141537)

  • 1. OPHTHALMIC APPLICATIONS of SLN and NLC.
    Okur NU; Gokce EH
    Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29141537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.
    Balguri SP; Adelli GR; Majumdar S
    Eur J Pharm Biopharm; 2016 Dec; 109():224-235. PubMed ID: 27793755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Delivery Routes And Strategies For Solid Lipid Nanoparticles (Sln) And Nanostructured Lipid Carriers (Nlc).
    Shastri DH
    Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29173154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.
    Souto EB; Doktorovova S; Gonzalez-Mira E; Egea MA; Garcia ML
    Curr Eye Res; 2010 Jul; 35(7):537-52. PubMed ID: 20597640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
    Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
    Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
    Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
    Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management.
    Jounaki K; Makhmalzadeh BS; Feghhi M; Heidarian A
    Eur J Pharm Sci; 2021 Dec; 167():105991. PubMed ID: 34517103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines for ocular NSAIDs: safety on drug delivery.
    Araújo J; Gonzalez E; Egea MA; Garcia ML; Souto EB
    Nanomedicine; 2009 Dec; 5(4):394-401. PubMed ID: 19341814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
    Shidhaye SS; Vaidya R; Sutar S; Patwardhan A; Kadam VJ
    Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications.
    Youssef AAA; Dudhipala N; Majumdar S
    Int J Nanomedicine; 2022; 17():2283-2299. PubMed ID: 35611213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
    Sah AK; Suresh PK
    Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured Lipid Carrier-loaded In situ Gel for Ophthalmic Drug Delivery: Preparation and In vitro Characterization Studies.
    Sabale V; Belokar V; Jiwankar M; Sabale P
    Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38213174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of Nanostructured Lipid Carriers and its Application in Drug Delivery through Different Routes.
    Khan S; Sharma A; Jain V
    Adv Pharm Bull; 2023 Jul; 13(3):446-460. PubMed ID: 37646052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
    Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
    Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part I - Barriers and determining factors in ocular delivery.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():70-75. PubMed ID: 27789358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.